News | January 28, 2022
Dr Reddy’s Q3FY22 PAT at Rs. 706 cr.
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended December 31, 2021
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended December 31, 2021
KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)
Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant
The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid
Madhavbaug has a pan-India presence with a vast network of 272 clinics and two hospitals
Avra Labs is a Hyderabad based contract manufacturing and research services (CRAMs) and specialty active pharmaceutical ingredients (API) manufacturer with four facilities across the states of Telangana and Andhra Pradesh
CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
Dr Woler joins Sygnature Discovery after the company received significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co, in 2021
This test analyses samples in VTM directly without the need for RNA extraction step
Subscribe To Our Newsletter & Stay Updated
